Paul O'Byrne
Paul O'Byrne, M.B., B.Ch., B.A.O., FRCPI, FRCPC, FRCP(Edin), FRCP(Glas) is a Canadian respirologist and the Dean and Vice President-elect of the Faculty of Health Sciences and Dean-elect of the Michael G. DeGroote School of Medicine at McMaster University. He is also the E.J. Moran Chair of Respiratory Medicine at McMaster University Medical School.[1]
Early life and education
O'Byrne was born in Ireland and grew up in South Africa. He was a childhood asthmatic and that inspired him to pursue asthma research. He went to medical school at University College Dublin and completed his residency in internal medicine and fellowship in respiratory medicine at McMaster University.[2] He completed further research fellowship training at McMaster University and at the Cardiovascular Research Institute in San Francisco.
Career
O'Byrne returned to McMaster and conducted asthma research. In 1998, he was appointed to the E.J. Moran Chair of Respiratory Medicine at the university and he is currently the executive director of the Firestone Institute for Respiratory Health and the Chair of the Department of Medicine at McMaster University.[3]
Research
O'Byrne tested a new antibody called AMG 157 which was shown to be effective at reducing the severity of allergic asthma attacks.[4]
References
- ↑ "Paul O'Byrne to be new dean & vice-president of the Faculty of Health Sciences". McMaster University. McMaster University. Retrieved 11 December 2015.
- ↑ Frketich, Joanna. "Asthma and allergy doctor Paul O’Byrne named head of health sciences at McMaster University". Hamilton Spectator. Hamilton Spectator. Retrieved 11 December 2015.
- ↑ "Paul O’Byrne". McMaster University. McMaster University. Retrieved 11 December 2015.
- ↑ Gauvreau, Gail M.; O'Byrne, Paul M. (2014). "Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses". NEJM 370. Retrieved 11 December 2015.